A Hematology Case Study

download A Hematology Case Study

of 40

Transcript of A Hematology Case Study

  • 8/3/2019 A Hematology Case Study

    1/40

  • 8/3/2019 A Hematology Case Study

    2/40

    Dr. Wael Lotfy Heikal

    M.B.B.CH, MSC Clinical Pathology

    Pathologist Khasab Hospital Laboratory

  • 8/3/2019 A Hematology Case Study

    3/40

    A football player who had dropped

    from the teamA 35 year-old man was dropped from the

    football team.

    He admitted to the coach that he had beenfeeling unusually tired for the last 6 monthsand had occasional episodes of sweating,

    especially at night.He went to his family doctor.

  • 8/3/2019 A Hematology Case Study

    4/40

    The only additional symptom that he mentionedwas occasional discomfort in his left upper

    abdomen.

    He didn't smoke and he consumed 20 units ofalcohol weekly . He had never been in hospital ,was taking no medication and denied the use ofrecreational drugs.

  • 8/3/2019 A Hematology Case Study

    5/40

    What might be causing his symptom?

    y Fatigue could be caused by anaemia

    or depression ,

    and " sweating" could be

    a manifestation of infection.

  • 8/3/2019 A Hematology Case Study

    6/40

  • 8/3/2019 A Hematology Case Study

    7/40

    What should be done next?

    yA full physical examination.

    y The man appeared healthy.

    y There was no evidence of weight loss and the onlyabnormal finding was an enlarged spleen, palpable4cm below the left costal margine on quietinspiration.

    y There was no lymphadenopathy & his chest was

    clinically clear.

  • 8/3/2019 A Hematology Case Study

    8/40

    Where is the spleen in a healthy individual?

    y The spleen lies between the 9th and 11th ribs posteriorly.

    y It is not normally palpable.

    y Occasionally in a very thin individual you may be able topalpate the tip of the spleen on deep inspiration.

    y In this case the spleen was easily palpable on quietinspiration and, therefore, is significantly enlarged.

  • 8/3/2019 A Hematology Case Study

    9/40

    What diseases might cause an enlarged spleen in

    an otherwise healthy looking young man?

    A palpable spleen in an otherwise healthy lookingyoung man suggests either a hematological disorderor an increase in blood flow through the spleen,causing it to enlarge( e.g. portal hypertension).

    In tropical areas infections such as malaria &schistosomiasis may cause a large spleen.

  • 8/3/2019 A Hematology Case Study

    10/40

    y It is reliable for anexperienced examiner.

    yHowever, in obeseindividuals it may bevery difficult to feel aslightly enlarged spleen.

  • 8/3/2019 A Hematology Case Study

    11/40

    What investigations will define the size of the spleen?

    Ultrasound examination

    of the abdomen is

    a reliable, non-invasive,inexpensive test.

  • 8/3/2019 A Hematology Case Study

    12/40

    What investigations might help to find the cause of the

    enlarged spleen?

    yA full blood count, blood film, reticulocyte count

    and a biochemical screen.

  • 8/3/2019 A Hematology Case Study

    13/40

    Normal range (male)Patient's results

    13.5-18.0 g/dl14.0 g/dlHb

    4.0-11.0x109/l (103/l)55.0x 109 /lWBC

    140-450x 109/l (103/l)600x109 /lPlatelets

    20-100x109/l (0.2-1.5%)6.4%Reticulocyte count

    Full blood & reticulocyte count

  • 8/3/2019 A Hematology Case Study

    14/40

    The blood film

    y There was a marked

    increase in the white

    cell count.y White cell precursors

    including

    metamyelocytes,

    myelocytes, andpromyelocytes were

    present

  • 8/3/2019 A Hematology Case Study

    15/40

  • 8/3/2019 A Hematology Case Study

    16/40

    basophil blast

    neutrophils

    and

    precursors promyelocyte

    CML

  • 8/3/2019 A Hematology Case Study

    17/40

    What do these blood results indicate?

    y The Hb is normal and the white cell count is elevated.

    y White cell precursors are present.,These cells are normally foundin the bone marrow and not in the peripheral blood.

    y The platelet count is also elevated.

    y This suggests that the bone marrow is overactive and releasing

    white cells and platelets prematurely into the circulation.

    y The results of these tests therefore suggest a sever disturbance ofthe bone marrow, not an infectious disease.

  • 8/3/2019 A Hematology Case Study

    18/40

    What should be done next?

    y He should be referred to a hematologist because hehas significant haematological disorders.

    y The patient received an appointment to see ahaematologist 2 days later.

    y He was adviced not to play football and to avoidstrenuous exercise.

  • 8/3/2019 A Hematology Case Study

    19/40

    Why was this advice given?

    y It is possible to rupture an enlarged spleenfollowing trauma.,This could lead to life

    threatening intra-abdominal bleeding.

    y He was interviewed and examined by thehematologist,who repeated the blood count and

    blood film and received the results of thebiochemical screen & ultrasound examination.

  • 8/3/2019 A Hematology Case Study

    20/40

    How would the hematologist interpret the

    blood finding?

    y The most likely diagnosis in a young man with a large spleenand with this blood picture is chronic myeloid leukaemia(CML).

    y It is possible in sever infections or when there are marrowmetastases to have an elevated white cell count and to see whitecell and red cell precursors in the blood ( a leucoerythroblasticblood picture) .

    y There are a number of possible causes of large spleen, such aschronic infection with malaria, liver disease with portalhypertension, non-Hodgkin's lymphomas and chroniclymphocytic leukaemia, but none of these conditions will havethe peripheral finding as described in this patient.

  • 8/3/2019 A Hematology Case Study

    21/40

    Normal rangePatient's result

    230-450IU/l850 IU/lLactic dehydrogenase(LDH)

    150-470 mol/l

    (3-8mg/dl)

    600mol/lUrate(uric acid)

    Lactic dehydrogenase andurate( uric acid) results:

  • 8/3/2019 A Hematology Case Study

    22/40

    How are the biochemical results explained?

    y The elevated LDH reflects cell death and is non-specific.

    y It could be elevated following myocardialinfarction, liver damage or premature death ofblood cells.,In this case it reflects death of whiteblood cells.

    y Similarly the elevated uric acid level in the plasmareflects increased cell turnover.

  • 8/3/2019 A Hematology Case Study

    23/40

    What should be done next?

    yA bone marrow examination was arranged since aserious hematological disorder was suspected.

  • 8/3/2019 A Hematology Case Study

    24/40

    From which site was the bone marrow

    aspirated?

    yThe posterior iliac crest. It is the

    least painful site for the patient

    and almost completely without

    hazard.

    yCare should be taken to make

    sure that adequate local

    analegesia is given and there isno bleeding after the procedure.

  • 8/3/2019 A Hematology Case Study

    25/40

    What investigations would the hematologist

    request on the sample of bone marrow?

    y Slides for microscopic examinations.

    yA sample should be also sent to the genetics

    department for a karyotypic (cytogenetic) analysis

  • 8/3/2019 A Hematology Case Study

    26/40

    How does the bone marrow aspirate help to confirm the

    suspected diagnosis?

    The slides revealed:1- a very cellular specimen withincreased numbers of white blood cellE/G ratio: 1:4 1: 10 and,

    2- increased number of plateletprecursors( megakaryocytes),

    3-variable fibrosis, increase in reticulin.,

    suggesting increased marrow activity or

    reduced cell death ( apoptosis).

  • 8/3/2019 A Hematology Case Study

    27/40

    How should the patient be managed?

    y The probable diagnosis should be explained to the patient.

    y If he has a partner she should be invited, with the

    patients permission, to come back in a few days to discussthe result of the result of the outstanding tests.

    y The patient should be assured that there is no immediatedanger, but he advised to remain off work and refrain from

    contact sports until the diagnosis is clarified.

  • 8/3/2019 A Hematology Case Study

    28/40

    What medications would the hematologist prescribe?

    y Allopurinol, a competitive inhibitor of xanthine oxidase.,This drugwill reduce urate(uric acid) in plasma and decrease the risk of gout andrenal damage.

    y The patient and his partner were given the results 3 days later.

    y The cytogenetic analysis revealed a normal number ofchromosomes but a small chromosome number 22.

    y This was due to translocation of a portion of chromosome 9 tochromosome 22 and a reciprocal ( reverse) transfer of a portion ofchromosome from chromosome 22 to chromosome 9.

  • 8/3/2019 A Hematology Case Study

    29/40

    Philadelphia chromosome. A piece of chromosome 9 and a piece of chromosome 22 break off and trade places. The bcr-abl gene is formed on

    chromosome 22 where the piece of chromosome 9 attaches. The changed chromosome 22 is called the Philadelphia chromosome.

  • 8/3/2019 A Hematology Case Study

    30/40

    Figure, The abnormally small chromosome22, the Philadelphia chromosome

    y Molecular consequence ofthe t(9;22) is the fusionprotein BCRABL, whichhas increased in tyrosinekinase activity

    y BCR-ABL proteintransform hematopoieticcells so that their growthand survival become

    independent of cytokinesy It protects hematopoietic

    cells from programmed celldeath (apoptosis)

  • 8/3/2019 A Hematology Case Study

    31/40

    Figure, FISH analysis( fluorescent in situ hybridization) of bone marrow cells showing

    fusion of BCR/ABL.(F).

  • 8/3/2019 A Hematology Case Study

    32/40

    Why is this small chromosome 22 called the Philadelphia

    chromosome and what is its significance?

    y The small, abnormal chromosome 22 was firstdescribed by two scientists in patients with CML inPhiladelphia.

    y This translocation was the first non-random,reproducible chromosome abnormality to bedescribed in a human cancer.

    y It is always present in the bone marrow cells ofpatients with CML.,

    y It is very significant in our understanding of thepathogenesis of CML.

  • 8/3/2019 A Hematology Case Study

    33/40

    y When portions of different chromosomes come together theproduction of an abnormal gene product(protein) occurs.

    y In the case of CML the abnormal gene product influences celldivision and programmed cell death (apoptosis).

    y The fusion gene on chromosome 22 is called BCR/ABL.

  • 8/3/2019 A Hematology Case Study

    34/40

    Key point:

    y The abnormal chromosome found in CML

    causes the malignant phenotype i.e. makes the cells

    behave in a cancerous way.

    y In very recent times this knowledge has

    stimulated the development of drugs whichspecifically inhibit these abnormalities and induceapoptosis of the leukemia cells.

  • 8/3/2019 A Hematology Case Study

    35/40

    What is the long term outlook for the patient?

    y The only definitive treatment is a stem cell transplant from a HLA

    compatible sibling.

    y As this patient has no siblings he will be treated medically.

    y A search for a HLA compatible volunteer donor should be carried out

    ( there are over 6 million donors on the international panel).

    y If as suitable donor is found, consideration should be given to a stem

    cell transplant, depending to his response to medical treatment.

  • 8/3/2019 A Hematology Case Study

    36/40

    Can you construct an algorithm for investigations of a patient with ahigh white cell count and a large spleen?

    A patient who has minor symptoms is found to havean elevated white blood cell count

    Complete physical examination

    Enlarged spleen

    white cell precursors in blood film

  • 8/3/2019 A Hematology Case Study

    37/40

    Confirmation of enlarged spleen

    Marrow for morphological examination and cytogeneticanalysis

    Normal chromosome number but small chromosome 22.

    Philadelphia' chromosome

    Diagnosis: chronic myeloid leukaemia

    Medical treatment initially and consideration for stemcell transplantation

    u come:

  • 8/3/2019 A Hematology Case Study

    38/40

    u come:

    y Imatinibmesylate, a new agent capable ofinducing apoptosis in the leukaemia cells, was

    prescribed.

    y He returned to work a few days and was ableto resume a normal life.

    y He is seen in the hematology clinic atmonthly intervals.

  • 8/3/2019 A Hematology Case Study

    39/40

  • 8/3/2019 A Hematology Case Study

    40/40

    Thank you